{"id":100159359,"date":"2026-09-05T10:40:00","date_gmt":"2026-09-05T07:40:00","guid":{"rendered":"https:\/\/europeanhealtheconomics.com\/?p=100159359"},"modified":"2026-09-12T11:00:07","modified_gmt":"2026-09-12T08:00:07","slug":"lead-market-access-strategy","status":"publish","type":"post","link":"https:\/\/europeanhealtheconomics.com\/fr\/north-america\/canada\/lead-market-access-strategy\/","title":{"rendered":"Lead Market Access Strategy"},"content":{"rendered":"<p><strong>Mississauga, Canada.<\/strong><\/p>\n<p>Lead, Market Access Strategy Hybrid eligible, On site 3 days a week At Gilead, Creating Possible drives everything we do. It\u2019s evident in our mission and core values. This is how we built a culture of excellence that is fuelled by a passion for improving the lives of people around the world and advancing the care of patients suffering from life-threatening diseases. We are driven to develop lifesaving products that make a difference for patients around the world. Every day, we aim to transform the promise of science and technology into breakthrough, innovative therapies that have the power to cure, prevent or treat disease. As a research-based bio pharmaceutical company, we are revolutionizing healthcare by bringing medicines to patients in the areas of high unmet need including HCV and other Liver diseases, HIV\/AIDS, Haematology, Oncology, and Inflammatory Diseases. When you join Gilead, you join our mission to change the world by enabling people to live healthier and more fulfilling lives. The Role: The Market Access Strategy Lead reports to the Director, Market Access Strategy. The successful candidate will be responsible for the planning and execution of the market access strategy for their aligned therapeutic area within Gilead\u2019s portfolio. This will include strategies for both public and private payers as well as non-traditional payers such as Public Health. The role is responsible for the oversight and management of strategic market access projects in their therapeutic area in pipeline, pre-, peri- and post-launch. You will improve the lives of Canadians by building relationships and work closely with departmental and cross functional colleagues in a fast-paced environment to achieve and maintain access to Gilead products. Through this role you will grow and be challenged in our diverse culture that will broaden your skills and expand your outreach in several therapeutic areas. Through the appropriate engagement of external stakeholders in the Canadian reimbursement environment, you will make a real difference in the lives of patients.<\/p>\n<ul>\n<li>Ensure effective development, strategic planning and seamless execution of key deliverables, including submissions to Canadian health technology agencies; submissions to provincial and private payers; and pre-launch planning as well as post launch execution<\/li>\n<li>Lead market access operational excellence through strategic pricing as well as PMPRB and PLA analysis across relevant therapeutic area aligned with the Pricing &#038; Negotiations Lead<\/li>\n<li>Lead the development and execution of a project management function to support market-access focused launch excellence and planning for the assigned therapeutic area<\/li>\n<li>Coordinate and support cross-functional project teams to create and execute key market access strategic initiatives that support commercial organizational objectives, including the planning and execution of private and public reimbursement strategies, brand planning, and product negotiations<\/li>\n<li>Maintain comprehensive acumen of the latest processes, policies, and trends within the Canadian market access and reimbursement environment to enable successful execution of strategic market access plans<\/li>\n<li>Partner with global colleagues to leverage and adapt organizational tools and frameworks to optimize launch planning and execution for the Canadian market access environment<\/li>\n<li>Engage local and global cross-functional colleagues to identify opportunities to increase efficiency in project management<\/li>\n<li>Manage program budgets and invoices<\/li>\n<li>Assist in the development and execution (where needed) of the negotiation\u2019s strategy<\/li>\n<li>Pull through the provincial PLAs following the issuance of the LOI from pCPA<\/li>\n<li>Work together with the field access therapeutic lead to drive access and ensure a suitable environment across Canada for facilitating access to Gilead\u2019s products<\/li>\n<\/ul>\n<p>Knowledge, Experience and Skills:<\/p>\n<ul>\n<li>6+ years within the biopharma\/pharmaceutical industry with experience in pharmaceutical pricing (GtN) and payer negotiations (public and private)<\/li>\n<li>Advanced degree in science, economics, public health, business, or related field of study would be an asset<\/li>\n<li>Excellent communication and negotiations skills and demonstrated clear decision making; a strategic mindset and project management and related business analytics, including using project management software<\/li>\n<li>Experience and knowledge in Canadian access and reimbursement of products in across Gilead\u2019s therapeutic areas would be an asset.<\/li>\n<li>Demonstrated experience in health economic\/pharmacoeconomic modeling and health technology assessment process would be an asset; ability to perform budget and financial forecasting and analyses, including experience with spreadsheets and market analytics<\/li>\n<li>Superior analytics skills, detailed oriented with exceptional organizational skills<\/li>\n<li>Experience in Canadian pricing environment, with demonstrated expertise to develop strategic pricing options and expertise to support reimbursement negotiations<\/li>\n<li>Ability to work with cross-functional teams to deliver exceptional results, managing multiple complex projects simultaneously<\/li>\n<li>Ability to manage people (AD*)<\/li>\n<li>Comfortable and adaptive to working in a changing ambiguous environment<\/li>\n<li>Bilingual (English and French) written and verbal skills an asset<\/li>\n<\/ul>\n<p>The salary range for this position is CAD $158,355 &#8211; $204,930 annually. In addition, this role is eligible for a discretionary target annual bonus. Gilead determines base compensation by considering factors such as experience, qualifications, and geographic location. As a result, actual compensation may vary.<\/p>\n<p>This job is posted by Gilead.<\/p>\n<p><a class=\"button\" href=\"https:\/\/gilead.wd1.myworkdayjobs.com\/en-US\/gileadcareers\/job\/Canada---Ontario---Mississauga\/Lead--Market-Access-Strategy_R0052665-2\" target=\"_blank\" rel=\"noopener\" aria-label=\"Apply for the Lead Market Access Strategy job at Gilead\" title=\"Apply for the Lead Market Access Strategy job at Gilead\">APPLY FOR JOB<\/a><\/p>\n<p><em>This link brings you to the website of Gilead.<\/em><\/p>\n<p><strong>Please mention that you found the role via EuropeanHealthEconomics.com.<\/strong> Thank you and good luck!<\/p>\n<p><script type=\"application\/ld+json\">{\n    \"@context\": \"https:\\\/\\\/schema.org\",\n    \"@type\": \"JobPosting\",\n    \"title\": \"Lead Market Access Strategy\",\n    \"description\": \"Lead, Market Access Strategy Hybrid eligible, On site 3 days a week At Gilead, Creating Possible drives everything we do. It\\u2019s evident in our mission and core values. This is how we built a culture of excellence that is fuelled by a passion for improving the lives of people around the world and advancing the care of patients suffering from life-threatening diseases. We are driven to develop lifesaving products that make a difference for patients around the world. Every day, we aim to transform the promise of science and technology into breakthrough, innovative therapies that have the power to cure, prevent or treat disease. As a research-based bio pharmaceutical company, we are revolutionizing healthcare by bringing medicines to patients in the areas of high unmet need including HCV and other Liver diseases, HIV\\\/AIDS, Haematology, Oncology, and Inflammatory Diseases. When you join Gilead, you join our mission to change the world by enabling people to live healthier and more fulfilling lives. The Role: The Market Access Strategy Lead reports to the Director, Market Access Strategy. The successful candidate will be responsible for the planning and execution of the market access strategy for their aligned therapeutic area within Gilead\\u2019s portfolio. This will include strategies for both public and private payers as well as non-traditional payers such as Public Health. The role is responsible for the oversight and management of strategic market access projects in their therapeutic area in pipeline, pre-, peri- and post-launch. You will improve the lives of Canadians by building relationships and work closely with departmental and cross functional colleagues in a fast-paced environment to achieve and maintain access to Gilead products. Through this role you will grow and be challenged in our diverse culture that will broaden your skills and expand your outreach in several therapeutic areas. Through the appropriate engagement of external stakeholders in the Canadian reimbursement environment, you will make a real difference in the lives of patients. Ensure effective development, strategic planning and seamless execution of key deliverables, including submissions to Canadian health technology agencies; submissions to provincial and private payers; and pre-launch planning as well as post launch execution Lead market access operational excellence through strategic pricing as well as PMPRB and PLA analysis across relevant therapeutic area aligned with the Pricing & Negotiations Lead Lead the development and execution of a project management function to support market-access focused launch excellence and planning for the assigned therapeutic area Coordinate and support cross-functional project teams to create and execute key market access strategic initiatives that support commercial organizational objectives, including the planning and execution of private and public reimbursement strategies, brand planning, and product negotiations Maintain comprehensive acumen of the latest processes, policies, and trends within the Canadian market access and reimbursement environment to enable successful execution of strategic market access plans Partner with global colleagues to leverage and adapt organizational tools and frameworks to optimize launch planning and execution for the Canadian market access environment Engage local and global cross-functional colleagues to identify opportunities to increase efficiency in project management Manage program budgets and invoices Assist in the development and execution (where needed) of the negotiation\\u2019s strategy Pull through the provincial PLAs following the issuance of the LOI from pCPA Work together with the field access therapeutic lead to drive access and ensure a suitable environment across Canada for facilitating access to Gilead\\u2019s products Knowledge, Experience and Skills: 6+ years within the biopharma\\\/pharmaceutical industry with experience in pharmaceutical pricing (GtN) and payer negotiations (public and private) Advanced degree in science, economics, public health, business, or related field of study would be an asset Excellent communication and negotiations skills and demonstrated clear decision making; a strategic mindset and project management and related business analytics, including using project management software Experience and knowledge in Canadian access and reimbursement of products in across Gilead\\u2019s therapeutic areas would be an asset. Demonstrated experience in health economic\\\/pharmacoeconomic modeling and health technology assessment process would be an asset; ability to perform budget and financial forecasting and analyses, including experience with spreadsheets and market analytics Superior analytics skills, detailed oriented with exceptional organizational skills Experience in Canadian pricing environment, with demonstrated expertise to develop strategic pricing options and expertise to support reimbursement negotiations Ability to work with cross-functional teams to deliver exceptional results, managing multiple complex projects simultaneously Ability to manage people (AD*) Comfortable and adaptive to working in a changing ambiguous environment Bilingual (English and French) written and verbal skills an asset The salary range for this position is CAD $158,355 - $204,930 annually. In addition, this role is eligible for a discretionary target annual bonus. Gilead determines base compensation by considering factors such as experience, qualifications, and geographic location. As a result, actual compensation may vary.\",\n    \"datePosted\": \"2026-09-05T10:40:00+03:00\",\n    \"hiringOrganization\": {\n        \"@type\": \"Organization\",\n        \"name\": \"Gilead\"\n    },\n    \"publisher\": {\n        \"@type\": \"Organization\",\n        \"name\": \"EuropeanHealthEconomics.com\",\n        \"logo\": \"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/European-Health-Economics-the-specialised-health-economist-job-board.png\"\n    },\n    \"jobLocation\": {\n        \"@type\": \"Place\",\n        \"address\": {\n            \"@type\": \"PostalAddress\",\n            \"addressCountry\": \"Canada\"\n        }\n    }\n}<\/script><\/p>","protected":false},"excerpt":{"rendered":"<p>Mississauga, Canada. Lead, Market Access Strategy Hybrid eligible, On site 3 days a week At Gilead, Creating Possible drives everything we do. It\u2019s evident in our mission and core values. This is how we built a culture of excellence that is fuelled by a passion for improving the lives of people around the world and advancing the care of patients &#8230; <a title=\"Lead Market Access Strategy\" class=\"read-more\" href=\"https:\/\/europeanhealtheconomics.com\/fr\/north-america\/canada\/lead-market-access-strategy\/\" aria-label=\"En savoir plus sur Lead Market Access Strategy\">En savoir plus<\/a><\/p>","protected":false},"author":1,"featured_media":100073387,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8850,27503],"tags":[3728,13027,27018,4214,3729,3910,5201,13087,2096,5202,7855,7252,24843,27536],"class_list":["post-100159359","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-canada","category-north-america","tag-director","tag-gilead","tag-global-health","tag-hta","tag-manager","tag-market-access","tag-modelling","tag-oncology","tag-pharmaceuticals","tag-pricing","tag-project-management","tag-reimbursement","tag-senior-level","tag-value-dossier","no-featured-image-padding"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lead Market Access Strategy - Mississauga, Canada | Gilead<\/title>\n<meta name=\"description\" content=\"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/europeanhealtheconomics.com\/fr\/amerique-du-nord\/canada\/lead-market-access-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lead Market Access Strategy - Mississauga, Canada | Gilead\" \/>\n<meta property=\"og:description\" content=\"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/europeanhealtheconomics.com\/fr\/amerique-du-nord\/canada\/lead-market-access-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"EuropeanHealthEconomics.com\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-05T07:40:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-12T08:00:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Jari Kempers\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/\"},\"author\":{\"name\":\"Jari Kempers\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#\\\/schema\\\/person\\\/f3945683d2bd69dd755b2e0c03a3fd3b\"},\"headline\":\"Lead Market Access Strategy\",\"datePublished\":\"2026-09-05T07:40:00+00:00\",\"dateModified\":\"2026-09-12T08:00:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/\"},\"wordCount\":828,\"publisher\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/Health-Economics-jobs-at-Gilead.webp\",\"keywords\":[\"Director\",\"Gilead\",\"Global Health\",\"HTA\",\"Manager\",\"Market Access\",\"Modelling\",\"Oncology\",\"Pharmaceuticals\",\"Pricing\",\"Project management\",\"Reimbursement\",\"Senior-level\",\"Value Dossier\"],\"articleSection\":[\"Canada\",\"North America\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/\",\"url\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/\",\"name\":\"Lead Market Access Strategy - Mississauga, Canada | Gilead\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/Health-Economics-jobs-at-Gilead.webp\",\"datePublished\":\"2026-09-05T07:40:00+00:00\",\"dateModified\":\"2026-09-12T08:00:07+00:00\",\"description\":\"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/Health-Economics-jobs-at-Gilead.webp\",\"contentUrl\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/Health-Economics-jobs-at-Gilead.webp\",\"width\":1200,\"height\":675,\"caption\":\"Gilead jobs for Health Economists\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/lead-market-access-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"North America\",\"item\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Canada\",\"item\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/north-america\\\/canada\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Lead Market Access Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#website\",\"url\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/\",\"name\":\"EuropeanHealthEconomics.com\",\"description\":\"The specialised job board for Health Economists\",\"publisher\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#organization\"},\"alternateName\":\"European Health Economics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#organization\",\"name\":\"EuropeanHealthEconomics.com\",\"alternateName\":\"European Health Economics\",\"url\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/European-Health-Economics-the-specialised-health-economist-job-board.png\",\"contentUrl\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/wp-content\\\/uploads\\\/European-Health-Economics-the-specialised-health-economist-job-board.png\",\"width\":512,\"height\":512,\"caption\":\"EuropeanHealthEconomics.com\"},\"image\":{\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/europeanhealtheconomics.com\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/europeanhealtheconomics.com\\\/#\\\/schema\\\/person\\\/f3945683d2bd69dd755b2e0c03a3fd3b\",\"name\":\"Jari Kempers\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g\",\"caption\":\"Jari Kempers\"},\"sameAs\":[\"https:\\\/\\\/europeanhealtheconomics.com\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/jarikempers\\\/\",\"https:\\\/\\\/x.com\\\/https:\\\/\\\/x.com\\\/EUROHEOR\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lead Market Access Strategy - Mississauga, Canada | Gilead","description":"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/europeanhealtheconomics.com\/fr\/amerique-du-nord\/canada\/lead-market-access-strategy\/","og_locale":"fr_FR","og_type":"article","og_title":"Lead Market Access Strategy - Mississauga, Canada | Gilead","og_description":"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.","og_url":"https:\/\/europeanhealtheconomics.com\/fr\/amerique-du-nord\/canada\/lead-market-access-strategy\/","og_site_name":"EuropeanHealthEconomics.com","article_published_time":"2026-09-05T07:40:00+00:00","article_modified_time":"2026-09-12T08:00:07+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp","type":"image\/webp"}],"author":"Jari Kempers","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#article","isPartOf":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/"},"author":{"name":"Jari Kempers","@id":"https:\/\/europeanhealtheconomics.com\/#\/schema\/person\/f3945683d2bd69dd755b2e0c03a3fd3b"},"headline":"Lead Market Access Strategy","datePublished":"2026-09-05T07:40:00+00:00","dateModified":"2026-09-12T08:00:07+00:00","mainEntityOfPage":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/"},"wordCount":828,"publisher":{"@id":"https:\/\/europeanhealtheconomics.com\/#organization"},"image":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp","keywords":["Director","Gilead","Global Health","HTA","Manager","Market Access","Modelling","Oncology","Pharmaceuticals","Pricing","Project management","Reimbursement","Senior-level","Value Dossier"],"articleSection":["Canada","North America"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/","url":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/","name":"Lead Market Access Strategy - Mississauga, Canada | Gilead","isPartOf":{"@id":"https:\/\/europeanhealtheconomics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#primaryimage"},"image":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp","datePublished":"2026-09-05T07:40:00+00:00","dateModified":"2026-09-12T08:00:07+00:00","description":"Join Gilead as a Lead Market Access Strategy. Explore health economics jobs and advance your career. Find your next job today.","breadcrumb":{"@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#primaryimage","url":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp","contentUrl":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/Health-Economics-jobs-at-Gilead.webp","width":1200,"height":675,"caption":"Gilead jobs for Health Economists"},{"@type":"BreadcrumbList","@id":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/lead-market-access-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/europeanhealtheconomics.com\/"},{"@type":"ListItem","position":2,"name":"North America","item":"https:\/\/europeanhealtheconomics.com\/north-america\/"},{"@type":"ListItem","position":3,"name":"Canada","item":"https:\/\/europeanhealtheconomics.com\/north-america\/canada\/"},{"@type":"ListItem","position":4,"name":"Lead Market Access Strategy"}]},{"@type":"WebSite","@id":"https:\/\/europeanhealtheconomics.com\/#website","url":"https:\/\/europeanhealtheconomics.com\/","name":"EuropeanHealthEconomics.com","description":"Le site d'emploi sp\u00e9cialis\u00e9 pour les \u00e9conomistes de la sant\u00e9","publisher":{"@id":"https:\/\/europeanhealtheconomics.com\/#organization"},"alternateName":"European Health Economics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/europeanhealtheconomics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/europeanhealtheconomics.com\/#organization","name":"EuropeanHealthEconomics.com","alternateName":"European Health Economics","url":"https:\/\/europeanhealtheconomics.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/europeanhealtheconomics.com\/#\/schema\/logo\/image\/","url":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/European-Health-Economics-the-specialised-health-economist-job-board.png","contentUrl":"https:\/\/europeanhealtheconomics.com\/wp-content\/uploads\/European-Health-Economics-the-specialised-health-economist-job-board.png","width":512,"height":512,"caption":"EuropeanHealthEconomics.com"},"image":{"@id":"https:\/\/europeanhealtheconomics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/europeanhealtheconomics.com\/"]},{"@type":"Person","@id":"https:\/\/europeanhealtheconomics.com\/#\/schema\/person\/f3945683d2bd69dd755b2e0c03a3fd3b","name":"Jari Kempers","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6433cb297f720dce97e1f2eebf492073b61167c05c8bb6c65a5f95e6315ec034?s=96&d=mm&r=g","caption":"Jari Kempers"},"sameAs":["https:\/\/europeanhealtheconomics.com","https:\/\/www.linkedin.com\/in\/jarikempers\/","https:\/\/x.com\/https:\/\/x.com\/EUROHEOR"]}]}},"_links":{"self":[{"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/posts\/100159359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/comments?post=100159359"}],"version-history":[{"count":2,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/posts\/100159359\/revisions"}],"predecessor-version":[{"id":100160605,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/posts\/100159359\/revisions\/100160605"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/media\/100073387"}],"wp:attachment":[{"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/media?parent=100159359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/categories?post=100159359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/europeanhealtheconomics.com\/fr\/wp-json\/wp\/v2\/tags?post=100159359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}